Flexion Therapeutics

$9.41
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.26 (-2.69%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell FLXN and other stocks, options, and ETFs commission-free!

About FLXN

Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis.

CEO
Michael D. Clayman
Employees
257
Headquarters
Burlington, Massachusetts
Founded
2015
Market Cap
416.20M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.14M
High Today
$9.75
Low Today
$9.20
Open Price
$9.73
Volume
572.23K
52 Week High
$14.39
52 Week Low
$7.52

FLXN Earnings

-$1.00
-$0.67
-$0.33
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, After Hours

You May Also Like

RYKKY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure